Telemedical, Intersectoral Network as New Digital Health Structure to Measurably Improve the Local Health Care

• Register: ClinicalTrials.gov
• Last refreshed on: 12 December 2020
• Main ID: NCT03137589
• Date of registration: 28/04/2017
• Prospective Registration: Yes
• Primary sponsor: RWTH Aachen University
• Public title: Telemedical, Intersectoral Network as New Digital Health Structure to Measurably Improve the Local Health Care TELnet@NRW
• Scientific title: Telemedical, Intersectoral Network as New Digital Health Structure to Measurably Improve the Local Health Care
• Date of first enrolment: May 1, 2017
• Target sample size: 159065
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT03137589
• Study type: Interventional
• Study design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
• Phase: N/A

Countries of recruitment

Germany

Contacts

• Name: Gernot Marx, Univ.-Prof. Dr. med.
• Affiliation: Clinic for Operative Intensive Care and Intermediate Care, University Hospital RWTH Aachen

Key inclusion & exclusion criteria

Inclusion Criteria:

- majority

- written informed consent

- infectiological and/or intensive care treatment

Exclusion Criteria:

- minority

- absence of written informed consent in the case of non-acute life-threatening disease

- persons who have a dependency or employment relationship with the sponsor or
investigator

- persons who are sheltered in an institution upon court or administrative order



Age minimum: 18 Years
Age maximum: N/A
Gender: All

Health Condition(s) or Problem(s) studied

Infection

Intensive Care Patients

Intervention(s)

Other: Telemedical support

Primary Outcome(s)

Improvement of treatment quality [Time Frame: through study completion, an average of 30 days up to a maximum of 1 year]

Secondary Outcome(s)

Rate of patients with dialysis [Time Frame: At discharge from Intensive Care Unit (study completion); after an average of 30 days up to a maximum of 1 year]

Rate of transfer transport [Time Frame: At discharge from Intensive Care Unit (study completion); after an average of 30 days up to a maximum of 1 year]

Sepsis therapy in compliance with guidelines [Time Frame: through study completion, an average of 30 days up to a maximum of 1 year]

Hospital mortality rate [Time Frame: through study completion, an average of 30 days up to a maximum of 1 year]

Rate of ARDS Diagnosis [Time Frame: through study completion, an average of 30 days up to a maximum of 1 year]

Hospital stay [Time Frame: At discharge from Hospital; after an average of 30 days up to a maximum of 1 year]

Rate of inadequate antibiotic therapies [Time Frame: through study completion, an average of 30 days up to a maximum of 1 year]

Sepsis mortality rate [Time Frame: through study completion, an average of 30 days up to a maximum of 1 year]

Rate of sepsis diagnosis [Time Frame: through study completion, an average of 30 days up to a maximum of 1 year]

Health-related quality of life (SF36-Questionnaire) [Time Frame: At discharge from Intensive Care Unit (through study completion; an average of 30 days up to a maximum of 1 year), through study completion, an average of 12 months and 24 months after discharge of ICU]

Rate of ARDS therapy according to guidelines [Time Frame: through study completion, an average of 30 days up to a maximum of 1 year]

Length of stay in intensive care unit [Time Frame: At discharge from Intensive Care Unit (study completion); after an average of 30 days up to a maximum of 1 year]

Rate of non-diagnosed sepsis [Time Frame: through study completion, an average of 30 days up to a maximum of 1 year]

Secondary ID(s)

16-162

Source(s) of Monetary Support

Please refer to primary and secondary sponsors